PatientPartner Raises $7M in Seed Funding to Transform Patient Engagement
Deal News | Dec 04, 2024 | FCA Venture Partners
PatientPartner, a health-tech startup founded by George Kramb and Patrick Frank, recently raised $7 million in Seed Round funding with FCA Venture Partners as the lead investor. The round included $3.5 million in new funding and $3.5 million of convertible debt from Alethea Capital and other strategic investors. This new capital will support PatientPartner's mission to elevate patient engagement and empowerment by expanding its unique mentorship platform. The platform connects patients with real-time mentors, achieving a high success rate of over 71% in facilitating patient progress in healthcare. The company serves pharmaceutical clients with innovative patient experiences, addressing the growing demand for personalized healthcare solutions. PatientPartner's platform has already attracted over 40,000 users and 500 mentors, serving a wide range of disease states and treatment types. Industry trend indicates increasing investments in direct-to-patient marketing by pharmaceutical giants like Eli Lilly and Pfizer. The fundraising underscores PatientPartner's leading role in patient engagement. FCA Venture Partners, a major player in healthcare technology investment, manages over $225 million and focuses on improving patient care and efficiency in healthcare delivery.
Sectors
- Health Technology
- Venture Capital
- Pharmaceuticals
Geography
- United States – The article references FCA Venture Partners, based in Nashville and Charlotte, and includes strategies for the U.S.-based pharmaceutical and health-tech markets.
Industry
- Health Technology – PatientPartner's platform operates in health technology, focusing on patient engagement and mentorship, making innovative use of technology to support patients' healthcare journeys.
- Venture Capital – FCA Venture Partners' involvement as a lead investor in the funding round highlights the venture capital industry's role in financing early-stage health technology innovators.
- Pharmaceuticals – PatientPartner provides services to pharmaceutical clients, leveraging its platform to enhance patient engagement for pharmaceutical products.
Financials
- $7M – Total funding raised by PatientPartner in its Seed Round.
- $3.5M – New money invested in PatientPartner's funding round.
- $3.5M – Convertible debt from Alethea Capital and other strategic investors.
Participants
Name | Role | Type | Description |
---|---|---|---|
PatientPartner | Target Company | Company | A health-tech startup revolutionizing patient engagement through a mentorship platform. |
FCA Venture Partners | Investor | Company | A venture capital firm investing in early-stage healthcare technology companies. |
Alethea Capital | Investor | Company | Contributor of convertible debt in PatientPartner's funding round. |
LionBird | Investor | Company | Supporter of PatientPartner's innovation in patient engagement. |
George Kramb | Co-Founder & CEO | Person | Co-founder and CEO of PatientPartner, a leader in developing patient empowerment solutions. |
Patrick Frank | Co-Founder & COO | Person | Co-founder and COO of PatientPartner, focusing on platform expansion and patient engagement. |
Ed Michael | Partner at LionBird | Person | Partner at LionBird, supporting PatientPartner's advancements in patient engagement. |